Year |
Citation |
Score |
2020 |
Karahoda R, Horackova H, Kastner P, Matthios A, Cerveny L, Kucera R, Kacerovsky M, Tebbens JD, Bonnin A, Abad C, Staud F. Serotonin homeostasis in the materno-fetal interface at term: role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO-A) in uptake and degradation of serotonin by human and rat term placenta. Acta Physiologica (Oxford, England). PMID 32311818 DOI: 10.1111/Apha.13478 |
0.48 |
|
2020 |
Velasquez JC, Zhao Q, Chan Y, Galindo LCM, Simasotchi C, Wu D, Hou Z, Herod SM, Oberlander TF, Gil S, Fournier T, Burd I, Andrews AM, Bonnin A. Correction to " Exposure to Citalopram Mitigates Maternal Stress Effects on Fetal Brain Development". Acs Chemical Neuroscience. PMID 31912736 DOI: 10.1021/Acschemneuro.9B00683 |
0.358 |
|
2019 |
Velasquez JC, Zhao Q, Chan Y, Galindo LCM, Simasotchi C, Wu D, Hou Z, Herod SM, Oberlander TF, Gil S, Fournier T, Burd I, Andrews AM, Bonnin A. In Utero Exposure to Citalopram Mitigates Maternal Stress Effects on Fetal Brain Development. Acs Chemical Neuroscience. PMID 31184110 DOI: 10.1021/Acschemneuro.9B00180 |
0.404 |
|
2019 |
Ranzil S, Ellery S, Walker DW, Vaillancourt C, Alfaidy N, Bonnin A, Borg A, Wallace EM, Ebeling PR, Erwich JJ, Murthi P. Disrupted placental serotonin synthetic pathway and increased placental serotonin: Potential implications in the pathogenesis of human fetal growth restriction. Placenta. PMID 31176514 DOI: 10.1016/j.placenta.2019.05.012 |
0.439 |
|
2018 |
da L D Barros M, Manhães-de-Castro R, Alves DT, Quevedo OG, Toscano AE, Bonnin A, Galindo L. Long term effects of neonatal exposure to fluoxetine on energy balance: a systematic review of experimental studies. European Journal of Pharmacology. PMID 29890156 DOI: 10.1016/J.Ejphar.2018.06.013 |
0.334 |
|
2018 |
Bonnin A. A Placenta-Specific Genetic Manipulation Reprograms Offspring Brain Development and Function. Biological Psychiatry. 82: 81-82. PMID 28645358 DOI: 10.1016/J.Biopsych.2017.05.005 |
0.322 |
|
2017 |
Goeden N, Notarangelo FM, Pocivavsek A, Beggiato S, Bonnin A, Schwarcz R. Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid. Developmental Neuroscience. PMID 29080891 DOI: 10.1159/000481168 |
0.35 |
|
2017 |
King JR, Velasquez JC, Torii M, Bonnin A. EFFECT OF MATERNAL ±CITALOPRAM EXPOSURE ON P11 EXPRESSION AND NEUROGENESIS IN THE MOUSE FETAL BRAIN. Acs Chemical Neuroscience. PMID 28076682 DOI: 10.1021/Acschemneuro.6B00339 |
0.444 |
|
2016 |
Muller CL, Anacker AM, Rogers TD, Goeden N, Keller EH, Forsberg CG, Kerr TM, Wender C, Anderson GM, Stanwood GD, Blakely RD, Bonnin A, Veenstra-VanderWeele J. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27550733 DOI: 10.1038/Npp.2016.166 |
0.704 |
|
2016 |
Goeden N, Velasquez J, Arnold KA, Chan Y, Lund BT, Anderson GM, Bonnin A. Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 6041-9. PMID 27251625 DOI: 10.1523/Jneurosci.2534-15.2016 |
0.594 |
|
2016 |
Brummelte S, Mc Glanaghy E, Bonnin A, Oberlander TF. Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience. PMID 26905950 DOI: 10.1016/J.Neuroscience.2016.02.037 |
0.557 |
|
2016 |
Velasquez JC, Goeden N, Herod SM, Bonnin A. Maternal pharmacokinetics and fetal disposition of (±)-citalopram during mouse pregnancy. Acs Chemical Neuroscience. PMID 26765210 DOI: 10.1021/Acschemneuro.5B00287 |
0.364 |
|
2016 |
Chan Y, Velasquez J, Bonnin A. 502: The effects of chronic unpredictable stress on maternal behavior and fetal brain development in a mouse model American Journal of Obstetrics and Gynecology. 214. DOI: 10.1016/J.Ajog.2015.10.545 |
0.335 |
|
2015 |
King J, Velasquez J, Bonnin A. 167: Effect of maternal SSRI antidepressants on p11 expression in the fetal brain American Journal of Obstetrics and Gynecology. 212. DOI: 10.1016/J.Ajog.2014.10.213 |
0.374 |
|
2014 |
Mader S, Brimberg L, Bonnin A, Bennett JL, Diamond B. AQP4-IgG placental transfer in NMO pregnancies Journal of Neuroimmunology. 275: 11. DOI: 10.1016/J.Jneuroim.2014.08.033 |
0.344 |
|
2013 |
Oury F, Khrimian L, Denny CA, Gardin A, Chamouni A, Goeden N, Huang YY, Lee H, Srinivas P, Gao XB, Suyama S, Langer T, Mann JJ, Horvath TL, Bonnin A, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. 155: 228-41. PMID 24074871 DOI: 10.1016/J.Cell.2013.08.042 |
0.368 |
|
2013 |
Velasquez JC, Goeden N, Bonnin A. Placental serotonin: implications for the developmental effects of SSRIs and maternal depression. Frontiers in Cellular Neuroscience. 7: 47. PMID 23630464 DOI: 10.3389/Fncel.2013.00047 |
0.508 |
|
2013 |
Goeden N, Bonnin A. Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy Nature Protocols. 8: 66-74. PMID 23237830 DOI: 10.1038/Nprot.2012.144 |
0.321 |
|
2013 |
Levitt P, Bonnin A. Placental serotonin, developmental programming and the fetal brain Neurotoxicology and Teratology. 37: 75. DOI: 10.1016/J.Ntt.2013.03.009 |
0.395 |
|
2012 |
van Kleef ES, Gaspar P, Bonnin A. Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development. The European Journal of Neuroscience. 35: 1563-72. PMID 22607002 DOI: 10.1111/J.1460-9568.2012.8096.X |
0.54 |
|
2012 |
Bonnin A, Zhang L, Blakely RD, Levitt P. The SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1879-84. PMID 22414815 DOI: 10.1038/Npp.2012.35 |
0.659 |
|
2012 |
Bonnin A, Levitt P. Placental source for 5-HT that tunes fetal brain development. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 299-300. PMID 22157865 DOI: 10.1038/Npp.2011.194 |
0.662 |
|
2011 |
Bonnin A, Levitt P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience. 197: 1-7. PMID 22001683 DOI: 10.1016/J.Neuroscience.2011.10.005 |
0.702 |
|
2011 |
Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC, Blakely RD, Deneris ES, Levitt P. A transient placental source of serotonin for the fetal forebrain. Nature. 472: 347-50. PMID 21512572 DOI: 10.1038/Nature09972 |
0.688 |
|
2007 |
Bonnin A, Torii M, Wang L, Rakic P, Levitt P. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nature Neuroscience. 10: 588-97. PMID 17450135 DOI: 10.1038/Nn1896 |
0.696 |
|
2006 |
Bonnin A, Peng W, Hewlett W, Levitt P. Expression mapping of 5-HT1 serotonin receptor subtypes during fetal and early postnatal mouse forebrain development. Neuroscience. 141: 781-94. PMID 16824687 DOI: 10.1016/J.Neuroscience.2006.04.036 |
0.647 |
|
2005 |
Eagleson KL, Bonnin A, Levitt P. Region- and age-specific deficits in γ-aminobutyric acidergic neuron development in the telencephalon of the uPAR-/- mouse Journal of Comparative Neurology. 489: 449-466. PMID 16025458 DOI: 10.1002/Cne.20647 |
0.479 |
|
2000 |
Chennaoui M, Grimaldi B, Fillion MP, Bonnin A, Drogou C, Fillion G, Guezennec CY. Effects of physical training on functional activity of 5-HT1B receptors in rat central nervous system: role of 5-HT-moduline. Naunyn-Schmiedeberg's Archives of Pharmacology. 361: 600-4. PMID 10882034 DOI: 10.1007/S002100000242 |
0.384 |
|
1999 |
Grimaldi B, Bonnin A, Fillion MP, Prudhomme N, Fillion G. 5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety. Neuroscience. 93: 1223-5. PMID 10501445 DOI: 10.1016/S0306-4522(99)00322-X |
0.425 |
|
1999 |
Bonnin A, Grimaldi B, Fillion MP, Fillion G. Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas. Brain Research. 825: 152-60. PMID 10216182 DOI: 10.1016/S0006-8993(99)01265-2 |
0.501 |
|
1998 |
Grimaldi B, Sibella-Arguelles C, Bonnin A, Fillion MP, Massot O, Rousselle JC, Seznec JC, Fillion G. Functional properties of 5-HT-moduline in the immune system: a model for central nervous system investigation. Annals of the New York Academy of Sciences. 861: 249-50. PMID 9928272 DOI: 10.1111/J.1749-6632.1998.Tb10206.X |
0.477 |
|
1998 |
Massot O, Rousselle JC, Grimaldi B, Cloëz-Tayarani I, Fillion MP, Plantefol M, Bonnin A, Prudhomme N, Fillion G. Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype. Annals of the New York Academy of Sciences. 861: 174-82. PMID 9928255 DOI: 10.1111/J.1749-6632.1998.Tb10189.X |
0.556 |
|
1998 |
Grimaldi B, Bonnin A, Fillion MP, Ruat M, Traiffort E, Fillion G. Characterization of 5-ht6 receptor and expression of 5-ht6 mRNA in the rat brain during ontogenetic development. Naunyn-Schmiedeberg's Archives of Pharmacology. 357: 393-400. PMID 9606024 DOI: 10.1007/Pl00005184 |
0.553 |
|
1998 |
Bonnin A, Grimaldi B, Fillion M-, Fillion G. Acute stress induces a differential increase of 5-HT moduline levels In various rat brain areas European Neuropsychopharmacology. 8. DOI: 10.1016/S0924-977X(98)80317-9 |
0.47 |
|
1998 |
Grimaldi B, Sibella-Arguelles C, Bonnin A, Fillion M-, Massot O, Rousselle J-, Prudhomme N, Fillion G. Control of the serotonergic activity and gene expression by 5-HT moduline European Neuropsychopharmacology. 8. DOI: 10.1016/S0924-977X(98)80035-7 |
0.494 |
|
1997 |
Grimaldi B, Fillion M-, Bonnin A, Rousselle JC, Massot O, Fillion G. Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain Neuropharmacology. 36: 1079-1087. PMID 9294973 DOI: 10.1016/S0028-3908(97)00099-3 |
0.48 |
|
1997 |
Fillion G, Massot O, Rousselle JC, Grimaldi B, Bonnin A, Fillion MP, Cloëz-Tayarani I, Seguin L, Seznec JC, Prudhomme N, Plantefol M. S.25.04 Modulation of serotonin 5HT1B receptor by an endogenous peptide European Neuropsychopharmacology. 7. DOI: 10.1016/S0924-977X(97)88440-4 |
0.331 |
|
Show low-probability matches. |